Jpmorgan Chase & Co »

Eikon Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $132k 10k 12.74
2026-03-31 $13k 1.3k 9.68

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
T. Rowe Price Associates
Vanguard Capital Management
EcoR1 Capital
Alliancebernstein
Geode Capital Management
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board

View all funds holding Eikon Therapeutics